REG - Wells Fargo & Co Amgen Inc. - Form 8.3 - Amgen Inc
01/12/2022 16:45
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221201:nRSA3321Ia&default-theme=true
RNS Number : 3321I Wells Fargo & Company 01 December 2022
Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
1. KEY INFORMATION
(a) Full name of discloser Wells Fargo & Co.
(b) Owner or controller of interests and short positions disclosed, if
different from 1(a)
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this Amgen Inc
form relates
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state
this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken 30/11/2022
For an opening position disclosure, state the latest practicable date prior to
the disclosure
(f) In addition to the company in 1(c) above, is the discloser also YES / NO / N/A
making disclosures in respect of any other party to the offer?
If YES, specify which: NO
If it is a cash offer or possible cash offer, state "N/A"
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security Common Stock (US0311621009)
(Note 3)
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled 7,398,044 1.386 0 0
(2) Cash-settled derivatives 0 0 0 0
(3) Stock-settled derivatives (including options) and agreements to 20,100 0.004 386 0.000
purchase/ sell
Total 7,418,144 1.390 386 0.000
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE
DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security
securities (Note 5) USD
Common Shares Purchase 1 279.68
Common Shares Purchase 2 280.22
Common Shares Purchase 575 286.4
Common Shares Purchase 838 286.53
Common Shares Purchase 61 280.14
Common Shares Purchase 26 284.90
Common Shares Sale 2 279.95
Common Shares Sale 10 280.34
Common Shares Sale 100 286.56
Common Shares Sale 225 286.59
Common Shares Sale 100 286.62
Common Shares Sale 25 286.63
Common Shares Sale 3 224.46
Common Shares Sale 1 240.51
Common Shares Sale 1 246.49
Common Shares Sale 1 250.35
Common Shares Sale 1 251.66
Common Shares Sale 18 279.04
Common Shares Sale 29 279.06
Common Shares Sale 10 279.08
Common Shares Sale 50 279.11
Common Shares Sale 40 279.18
Common Shares Sale 17 279.21
Common Shares Sale 2 279.24
Common Shares Sale 2 279.25
Common Shares Sale 3 279.27
Common Shares Sale 11 279.28
Common Shares Sale 8 279.29
Common Shares Sale 9 279.3
Common Shares Sale 15 279.35
Common Shares Sale 2 279.36
Common Shares Sale 13 279.39
Common Shares Sale 10 279.46
Common Shares Sale 24 279.49
Common Shares Sale 3 279.5
Common Shares Sale 1 279.51
Common Shares Sale 2 279.52
Common Shares Sale 1 279.54
Common Shares Sale 2 279.55
Common Shares Sale 18 279.57
Common Shares Sale 47 279.58
Common Shares Sale 9 279.6
Common Shares Sale 7 279.62
Common Shares Sale 10 279.63
Common Shares Sale 1 279.64
Common Shares Sale 3 279.67
Common Shares Sale 52 279.68
Common Shares Sale 4 279.69
Common Shares Sale 29 279.7
Common Shares Sale 1 279.73
Common Shares Sale 1 279.74
Common Shares Sale 96 279.75
Common Shares Sale 33 279.77
Common Shares Sale 100 279.82
Common Shares Sale 38 279.88
Common Shares Sale 56 279.89
Common Shares Sale 22 279.9
Common Shares Sale 3 279.91
Common Shares Sale 28 279.93
Common Shares Sale 1 279.94
Common Shares Sale 1 279.95
Common Shares Sale 2 279.97
Common Shares Sale 85 279.99
Common Shares Sale 17 280.02
Common Shares Sale 13 280.03
Common Shares Sale 27 280.04
Common Shares Sale 16 280.06
Common Shares Sale 4 280.08
Common Shares Sale 4 280.09
Common Shares Sale 2 280.11
Common Shares Sale 1 280.12
Common Shares Sale 11 280.13
Common Shares Sale 9 280.15
Common Shares Sale 1 280.19
Common Shares Sale 1 280.2
Common Shares Sale 42 280.21
Common Shares Sale 1 280.26
Common Shares Sale 2 280.27
Common Shares Sale 8 280.28
Common Shares Sale 14 280.32
Common Shares Sale 5 280.36
Common Shares Sale 49 280.37
Common Shares Sale 2 280.38
Common Shares Sale 50 280.4
Common Shares Sale 2 280.41
Common Shares Sale 5 280.43
Common Shares Sale 64 280.44
Common Shares Sale 3 280.45
Common Shares Sale 15 280.47
Common Shares Sale 27 280.48
Common Shares Sale 9 280.49
Common Shares Sale 10 280.5
Common Shares Sale 35 280.52
Common Shares Sale 5 280.53
Common Shares Sale 16 280.57
Common Shares Sale 7 280.62
Common Shares Sale 1 280.64
Common Shares Sale 10 280.68
Common Shares Sale 10 280.72
Common Shares Sale 86 280.76
Common Shares Sale 11 280.77
Common Shares Sale 2 280.79
Common Shares Sale 2 280.83
Common Shares Sale 3 280.84
Common Shares Sale 12 280.89
Common Shares Sale 3 281.05
Common Shares Sale 25 281.07
Common Shares Sale 1 281.1
Common Shares Sale 3 281.11
Common Shares Sale 27 281.13
Common Shares Sale 5 281.17
Common Shares Sale 50 281.18
Common Shares Sale 1 281.24
Common Shares Sale 2 281.49
Common Shares Sale 8 281.61
Common Shares Sale 1 281.84
Common Shares Sale 9 281.9
Common Shares Sale 8 281.91
Common Shares Sale 0 281.99
Common Shares Sale 7 282.01
Common Shares Sale 1 282.07
Common Shares Sale 1 282.14
Common Shares Sale 5 282.26
Common Shares Sale 1 282.37
Common Shares Sale 1 282.45
Common Shares Sale 200 282.51
Common Shares Sale 4 282.53
Common Shares Sale 33 282.56
Common Shares Sale 29 282.58
Common Shares Sale 1 282.6
Common Shares Sale 8 282.62
Common Shares Sale 20 282.67
Common Shares Sale 3 282.71
Common Shares Sale 6 282.74
Common Shares Sale 49 283.43
Common Shares Sale 3 283.49
Common Shares Sale 8 283.52
Common Shares Sale 7 283.53
Common Shares Sale 12 283.54
Common Shares Sale 95 283.58
Common Shares Sale 30 283.59
Common Shares Sale 5 283.6
Common Shares Sale 6 283.61
Common Shares Sale 47 283.65
Common Shares Sale 3 283.66
Common Shares Sale 31 283.69
Common Shares Sale 86 283.71
Common Shares Sale 1 283.76
Common Shares Sale 31 283.83
Common Shares Sale 1 283.86
Common Shares Sale 4 284
Common Shares Sale 6 284.13
Common Shares Sale 24 284.39
Common Shares Sale 1 284.57
Common Shares Sale 18 284.58
Common Shares Sale 3 284.75
Common Shares Sale 2 284.79
Common Shares Sale 1 284.8
Common Shares Sale 3 284.85
Common Shares Sale 7 284.87
Common Shares Sale 1 284.92
Common Shares Sale 2 285.03
Common Shares Sale 7 285.15
Common Shares Sale 1 285.51
Common Shares Sale 2 285.62
Common Shares Sale 74 285.64
Common Shares Sale 1 285.65
Common Shares Sale 2 285.72
Common Shares Sale 12 285.74
Common Shares Sale 15 285.75
Common Shares Sale 4 285.78
Common Shares Sale 100 285.92
Common Shares Sale 1 285.93
Common Shares Sale 69 285.95
Common Shares Sale 29 285.96
Common Shares Sale 4 285.99
Common Shares Sale 2 286
Common Shares Sale 43 286.01
Common Shares Sale 28 286.04
Common Shares Sale 3 286.06
Common Shares Sale 3 286.08
Common Shares Sale 1 286.11
Common Shares Sale 25 286.12
Common Shares Sale 1 286.15
Common Shares Sale 4 286.16
Common Shares Sale 2 286.23
Common Shares Sale 1 286.7
Common Shares Sale 100 287
Common Shares Purchase 11 242.66
Common Shares Purchase 15 279.06
Common Shares Purchase 3 279.08
Common Shares Purchase 70 279.09
Common Shares Purchase 1 279.12
Common Shares Purchase 5 279.13
Common Shares Purchase 1 279.18
Common Shares Purchase 22 279.22
Common Shares Purchase 1 279.23
Common Shares Purchase 10 279.24
Common Shares Purchase 10 279.27
Common Shares Purchase 80 279.28
Common Shares Purchase 170 279.43
Common Shares Purchase 2 279.5
Common Shares Purchase 5 279.52
Common Shares Purchase 9 279.54
Common Shares Purchase 9 279.56
Common Shares Purchase 9 279.57
Common Shares Purchase 14 279.59
Common Shares Purchase 2 279.6
Common Shares Purchase 81 279.65
Common Shares Purchase 547 279.67
Common Shares Purchase 37 279.68
Common Shares Purchase 42 279.69
Common Shares Purchase 24 279.7
Common Shares Purchase 3 279.72
Common Shares Purchase 462 279.75
Common Shares Purchase 2 279.78
Common Shares Purchase 3 279.8
Common Shares Purchase 54 279.81
Common Shares Purchase 15 279.82
Common Shares Purchase 3 279.9
Common Shares Purchase 1 279.91
Common Shares Purchase 69 279.92
Common Shares Purchase 6 279.94
Common Shares Purchase 355 279.95
Common Shares Purchase 18 279.96
Common Shares Purchase 89 279.98
Common Shares Purchase 101 279.99
Common Shares Purchase 24 280
Common Shares Purchase 30 280.02
Common Shares Purchase 12 280.03
Common Shares Purchase 28 280.04
Common Shares Purchase 25 280.05
Common Shares Purchase 61 280.06
Common Shares Purchase 7 280.08
Common Shares Purchase 2 280.09
Common Shares Purchase 35 280.1
Common Shares Purchase 100 280.13
Common Shares Purchase 94 280.14
Common Shares Purchase 2 280.19
Common Shares Purchase 5 280.22
Common Shares Purchase 1 280.24
Common Shares Purchase 2 280.27
Common Shares Purchase 1 280.33
Common Shares Purchase 155 280.34
Common Shares Purchase 1 280.37
Common Shares Purchase 11 280.38
Common Shares Purchase 25 280.41
Common Shares Purchase 29 280.42
Common Shares Purchase 213 280.43
Common Shares Purchase 48 280.44
Common Shares Purchase 11 280.45
Common Shares Purchase 2 280.46
Common Shares Purchase 2 280.47
Common Shares Purchase 5 280.48
Common Shares Purchase 13 280.5
Common Shares Purchase 2 280.53
Common Shares Purchase 9 280.54
Common Shares Purchase 11 280.58
Common Shares Purchase 11 280.7
Common Shares Purchase 7 280.71
Common Shares Purchase 305 280.75
Common Shares Purchase 4 280.91
Common Shares Purchase 6 281
Common Shares Purchase 4 281.03
Common Shares Purchase 5 281.06
Common Shares Purchase 1 281.1
Common Shares Purchase 7 281.13
Common Shares Purchase 167 281.36
Common Shares Purchase 1 281.37
Common Shares Purchase 62 281.41
Common Shares Purchase 8 281.47
Common Shares Purchase 15 281.79
Common Shares Purchase 59 281.83
Common Shares Purchase 250 281.84
Common Shares Purchase 57 281.96
Common Shares Purchase 3 281.97
Common Shares Purchase 10 281.99
Common Shares Purchase 4 282
Common Shares Purchase 12 282.01
Common Shares Purchase 1 282.06
Common Shares Purchase 44 282.1
Common Shares Purchase 2 282.48
Common Shares Purchase 4 282.53
Common Shares Purchase 200 282.56
Common Shares Purchase 8 282.79
Common Shares Purchase 25 282.87
Common Shares Purchase 45 283.4
Common Shares Purchase 667 283.42
Common Shares Purchase 27 283.52
Common Shares Purchase 65 283.55
Common Shares Purchase 27 283.56
Common Shares Purchase 43 283.58
Common Shares Purchase 34 283.62
Common Shares Purchase 113 283.63
Common Shares Purchase 4 283.66
Common Shares Purchase 18 283.69
Common Shares Purchase 35 283.7
Common Shares Purchase 3 283.73
Common Shares Purchase 1 283.81
Common Shares Purchase 8 283.84
Common Shares Purchase 51 284.06
Common Shares Purchase 33 284.34
Common Shares Purchase 4 284.38
Common Shares Purchase 9 284.52
Common Shares Purchase 10 284.55
Common Shares Purchase 38 284.56
Common Shares Purchase 30 284.65
Common Shares Purchase 5 284.71
Common Shares Purchase 30 284.73
Common Shares Purchase 9 284.76
Common Shares Purchase 46 284.8
Common Shares Purchase 3 284.84
Common Shares Purchase 12 284.87
Common Shares Purchase 4 285.12
Common Shares Purchase 64 285.16
Common Shares Purchase 1 285.33
Common Shares Purchase 4 285.54
Common Shares Purchase 23 285.58
Common Shares Purchase 2 285.71
Common Shares Purchase 5 285.75
Common Shares Purchase 2 285.76
Common Shares Purchase 11 285.78
Common Shares Purchase 20 285.79
Common Shares Purchase 21 285.8
Common Shares Purchase 1 285.83
Common Shares Purchase 11 285.86
Common Shares Purchase 19 285.94
Common Shares Purchase 1 285.95
Common Shares Purchase 7 285.98
Common Shares Purchase 11 286
Common Shares Purchase 15 286.09
Common Shares Purchase 3 286.13
Common Shares Purchase 105 286.14
Common Shares Purchase 12 286.19
Common Shares Purchase 10 286.23
Common Shares Purchase 12 286.24
Common Shares Purchase 10 286.25
Common Shares Purchase 25 286.29
Common Shares Purchase 4 286.35
Common Shares Purchase 7 286.4
Total Purchase Total Sale
7892 3486
Ap29
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price
relevant description e.g. opening/ closing a long/ short position, increasing/ reducing a long/ reference per unit
security e.g. CFD short position securities (Note 5)
(Note 6)
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, purchasing, selling, varying Number Exercise Type Expiry Option
relevant description e.g. call etc. of
price per e.g. date money
security option securities unit American,
paid/
to which European received per unit
option
etc.
relates
(Note 6)
(ii) Exercise
Class of Product Exercising/ Number of Exercise
relevant description exercised securities price per
security e.g. call against unit
option (Note 5)
(d) Other dealings (including transactions in respect of
new securities) (Note 3)
Class of Nature of dealing Details Price per unit (if
relevant e.g. subscription, applicable)
security conversion, exercise (Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to
options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
(c) Attachments
Is a Supplemental Form 8 attached? YES/NO
Date of disclosure 01/12/2022
Contact name Bukki Osula
Telephone number +44 (0)2039429419
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.
Ap31
NOTES ON FORM 8.3
1. See the definition of "connected fund manager" in
Rule 2.2 of Part A of the Rules.
2. See the definition of "interest in a relevant
security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of
Part B of the Rules.
3. See the definition of "relevant securities" in Rule
2.1 of Part A of the Rules.
4. See the definition of "dealing" in Rule 2.1 of Part
A of the Rules.
5. If the economic exposure to changes in the price of
securities is limited, for example, by virtue of a stop loss arrangement
relating to a spread bet, full details must be given.
6. See Rule 2.5(d) of Part A of the Rules.
7. If details included in a disclosure under Rule 8
are incorrect, they should be corrected as soon as practicable in a subsequent
disclosure. Such disclosure should state clearly that it corrects details
disclosed previously, identify the disclosure or disclosures being corrected,
and provide sufficient detail for the reader to understand the nature of the
corrections. In the case of any doubt, the Panel should be consulted.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act,
1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ISEBLBDDDSGDGDBRecent news on Wells Fargo & Co
See all newsREG - Wells Fargo & Co - Doc re. Form 8-K
AnnouncementREG - Wells Fargo & Co - Doc re. Form 10-Q
AnnouncementREG - Wells Fargo & Co - Doc re. Form 8-K
AnnouncementREG - Wells Fargo & Co - Doc re. Form 8-K
AnnouncementREG - Wells Fargo & Co - 1st Quarter Results
Announcement